Cantini, G., Fei, L., Canu, L., Lazzeri, E., Sottili, M., Francalanci, M., . . . Luconi, M. (2021). Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG.
Style de citation Chicago (17e éd.)Cantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.
Style de citation MLA (8e éd.)Cantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.